Calderasib
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Calderasib, covering 2026-02-11 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) [Phase 3]